Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
24 avr. 2023 17h50 HE
|
Trinity Biotech plc
DUBLIN, Ireland, April 24, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and...
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth
20 avr. 2023 08h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and...
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results
23 mars 2023 08h50 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 23, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm
22 mars 2023 11h10 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results
16 mars 2023 15h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 16, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions
22 févr. 2023 08h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
09 janv. 2023 08h00 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Q3 2022 Financial Results
15 déc. 2022 09h05 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
09 déc. 2022 05h35 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference
30 nov. 2022 05h50 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...